The liberal use of magnetic resonance cholangiopancreatography can be switched over to its selective use to detect choledocholithiasis

Authors

  • Altaf G. Haji Department of General and GI Surgery, George Elliot NHS Hospital, England
  • A.Elhassan Department of General and GI Surgery, George Elliot NHS Hospital, England
  • Mahmoud Elkadi Department of General and GI Surgery, George Elliot NHS Hospital, England
  • Naveen Sivakumar Department of General and GI Surgery, George Elliot NHS Hospital, England
  • Aftab Ahmad Department of General and GI Surgery, George Elliot NHS Hospital, England
  • Syed I. Haider Department of General and GI Surgery, George Elliot NHS Hospital, England
  • Bala Piramanayagam Department of General and GI Surgery, George Elliot NHS Hospital, England
  • Amitabh Palit Department of Radiology, George Elliot NHS Hospital, England

DOI:

https://doi.org/10.18203/2349-2902.isj20230303

Keywords:

Gall stones, MRCP, Choledocholithiasis, Liver enzymes

Abstract

Background: Gallstone disease is known in 10-15% of adults in Western populations. Magnetic resonance cholangiopancreatography (MRCP) is the investigation of choice for choledocholithiasis; however, its use is varied, and guidelines are not well defined. The National Institute for Health and Care (NICE) guidelines recommends MRCP to be done when common bile duct (CBD) dilatation ≥8 mm or liver function tests (LFTs) are abnormal but do not quantify this further. The liberal use of MRCP is gaining popularity as a roadmap prior to cholecystectomy, aiming to assess primarily for the presence of migrated gallstones within the cystic duct or common bile duct, as well as providing information regarding the anatomical features of the extrahepatic biliary tree on an individualised basis. Due to these reasons MRCP at times is done unnecessarily which creates economic burden and restricts access to patients in real need of imaging slots.

Methods: It is hospital based retrospective observational study. Time frame was July 2021 to July 2022 and sample size was 230 patients.

Results: Our study showed that isolated elevated alanine aminotransferase (ALT) level should not be reason to evaluate patients for choledocholithiasis. It concluded that elevated serum bilirubin levels, alkaline phosphatase (ALP) and gamma glutamyl transferase (GGT) are the strongest predictors of CBD stones in patients with gallstone disease and hence can be used to triage patients for undergoing MRCP.

Conclusions: To conclude elevated serum bilirubin levels, ALP and GGT are the strongest predictors of CBD stones in patients with gallstone disease and hence can be used to triage patients for undergoing MRCP. Isolated elevated ALT should not be a reason to evaluate patients for CBD stones.

References

Mitchell SA, Jacyna MR, Chadwick S. Common bile duct stones: a controversy revisited. Br J Surg. 1993;80:759-60.

Costi R, Gnocchi A, Di Mario F. Diagnosis and management of choledocholithiasis in the golden age of imaging, endoscopy and laparoscopy. World J Gastroenterol. 2014;20:13382-401.

Sanguanlosit S, Viriyaroj V, Yodying H, Rookkachart T, Sathornviriyapong S, Boonsinsukh T. The influence of stone size on spontaneous passage of common bile duct stones in patients with acute cholangitis: A retrospective cohort study. Ann Med Surg. 2020;60:72-5.

Barkun AN, Barkun JS, Fried GM, Ghitulescu G, Steinmetz O, Pham C, et al. Useful predictors of bile duct stones in patients undergoing laparoscopic cholecystectomy. Ann Surg. 1994;220(1):32-9.

Gurusamy KS, Giljaca V, Takwoingi Y, Higgie D, Poropat G, Štimac D, et al. Ultrasound versus liver function tests for diagnosis of common bile duct stones. Cochrane Database Syst Rev. 2015;(2).

Chen W, Mo JJ, Lin L, Li CQ, Zhang JF. Diagnostic value of magnetic resonance cholangiopancreatography in choledocholithiasis. World J Gastroenterol. 2015;21(11):3351-60.

Maple JT, Tamir BM, Anderson MA, et al. The role of endoscopy in the evaluation of suspected choledocholithiasis. Gastrointest Endosc. 2010;71:1-8.

Magalhaes J, Rosa B, Cotter J. Endoscopic retrograde cholangiopancreatography for suspected choledocholithiasis: from guidelines to clinical practice. World J Gastrointest Endosc. 2015;7:128-34.

Cynthia WK, Sum PL. Epidemiology and natural history of common bile duct stones and prediction of disease. Gastrointest Endosc. 2002;56(6 suppl):S165-9.

Narvaez-Rivera RM, Gonzalez-Gonzalez JA, Monreal-Robles R, Garcia-Compean D, Paz-Delgadillo J, Garza-Galindo AA, et al. Accuracy of ASGE criteria for the prediction of choledocholithiasis. Rev Esp Enferm Dig. 2016;108:309-14.

Makary MA, Duncan MD, Harmon JW, Freeswick PD, Bender JS, Bohlman M, et al. The role of magnetic resonance cholangiography in the management of patients with gallstone pancreatitis. Ann Surg. 2005;241:119-24.

Hallal AH, Amortegui JD, Jeroukhimov IM, Casillas J, Schulman CI, Manning RJ, et al. Magnetic resonance cholangiopancreatography accurately detects common bile duct stones in resolving gallstone pancreatitis. J Am Coll Surg. 2005;200:869–75. [PubMed] [Google Scholar]

Kejriwal R, Liang J, Anderson G, et al. Magnetic resonance imaging of the common bile duct to exclude choledocholithiasis. ANZ J Surg. 2004;74:619-21.

Miletic D, Uravic M, Mazur-Brbac M, Stimac D, Petranovic D, Sestan B. Role of magnetic resonance cholangiography in the diagnosis of bile duct lithiasis. World J Surg. 2006;30:1705-12.

Canena J. Once upon a Time a Guideline Was Used for the Evaluation of Suspected Choledocholithiasis: A Fairy Tale or a Nightmare? GE Port J Gastroenterol. 2018;25(1):6-9.

Singhvi G, Ampara R, Baum J, Gumaste V. ASGE guidelines result in cost-saving in the management of choledocholithiasis. Ann Gastroenterol. 2016;29(1):85-90.

Videhult P, Sandblom G, Rudberg C, Rasmussen IC. Are liver function tests, pancreatitis and cholecystitis predictors of common bile duct stones? Results of a prospective, population-based, cohort study of 1171 patients undergoing cholecystectomy. HPB (Oxford). 2011;13(8):519-27.

Sethi S, Wang F, Korson AS, Krishnan S, Berzin TM, Chuttani R, et al. Prospective assessment of consensus criteria for evaluation of patients with suspected choledocholithiasis. Dig Endosc. 2016;28(1):75-82.

Kuzu UB, Ödemiş B, Dişibeyaz S, Parlak E, Öztaş E, Saygılı F, et al. Management of suspected common bile duct stone: diagnostic yield of current guidelines. HPB (Oxford). 2017;19(2):126-32.

Peng WK, Sheikh Z, Paterson-Brown S, Nixon SJ. Role of liver function tests in predicting common bile duct stones in acute calculous cholecystitis. Br J Surg. 2005;92(10):1241-7.

Yang MH, Chen TH, Wang SE, Tsai YF, Su CH, Wu CW, et al. Biochemical predictors for absence of common bile duct stones in patients undergoing laparoscopic cholecystectomy. Surg Endosc. 2008;22(7):1620-4.

ISRCTN Registry. Testing for bile duct stones before gallbladder surgery. Available at: https://www.isrctn. com/ISRCTN10378861. Accessed on 12 December 2022.

Downloads

Published

2023-02-06

Issue

Section

Original Research Articles